Advertisement

Mastocytosis in Pregnancy

Published:October 27, 2022DOI:https://doi.org/10.1016/j.iac.2022.07.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Immunology and Allergy Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Theoharides T.C.
        • Valent P.
        • Akin C.
        Mast Cells, Mastocytosis, and Related Disorders.
        N Engl J Med. 2015; 373: 163-172https://doi.org/10.1056/NEJMra1409760
        • Cohen S.S.
        • Skovbo S.
        • Vestergaard H.
        • et al.
        Epidemiology of systemic mastocytosis in Denmark.
        Br J Haematol. 2014; 166: 521-528
        • Pulfer S.
        • Ziehfreund S.
        • Gebhard J.
        • et al.
        Health-Related Quality of Life and Influencing Factors in Adults with Nonadvanced Mastocytosis—A Cross-Sectional Study and Qualitative Approach.
        J Allergy Clin Immunol In Pract. 2021; 9: 3166-3175.e2
        • Carter M.C.
        • Metcalfe D.D.
        • Komarow H.D.
        Mastocytosis.
        Immunol Allergy Clin. 2014; 34: 181-196
        • Akin C.
        • Metcalfe D.D.
        Systemic mastocytosis.
        Annu Rev Med. 2004; 55: 419-432
        • Valent P.
        • Akin C.
        • Hartmann K.
        • et al.
        Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.
        Hemasphere. 2021; 5: e646
        • Siebenhaar F.
        • Akin C.
        • Bindslev-Jensen C.
        • et al.
        Treatment strategies in mastocytosis.
        Immunol Allergy Clin. 2014; 34: 433-447
        • Nanagas V.C.
        • Kovalszki A.
        Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
        Clin Rev Allergy Immunol. 2019; 57: 194-212
        • Georgin-Lavialle S.
        • Lhermitte L.
        • Dubreuil P.
        • et al.
        Mast cell leukemia.
        Blood. 2013; 121: 1285-1295
        • Weiler C.R.
        • Butterfield J.
        Mast cell sarcoma: clinical management.
        Immunol Allergy Clin North Am. 2014; 34: 423-432
        • Lei D.
        • Kovalszki A.
        Mastocytosis in Pregnancy.
        Mastocytosis. 2020; : 187-205
        • Lei D.
        • Akin C.
        • Kovalszki A.
        Management of Mastocytosis in Pregnancy: A Review.
        J Allergy Clin Immunol Pract. 2017; 5: 1217-1223
        • Matito A.
        • Alvarez-Twose I.
        • Morgado J.M.
        • et al.
        Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases.
        Int Arch Allergy Immunol. 2011; 156: 104-111
        • Norström A.
        • Radulovic N.V.
        • Bullarbo M.
        • et al.
        Mast cell involvement in human cervical ripening.
        Eur J Obstet Gynecol Reprod Biol. 2019; 238: 157-163
        • Elieh Ali Komi D.
        • Shafaghat F.
        • Haidl G.
        Significance of mast cells in spermatogenesis, implantation, pregnancy, and abortion: cross talk and molecular mechanisms.
        Am J Reprod Immunol. 2020; 83: e13228
        • Derbala Y.
        • Elazzamy H.
        • Bilal M.
        • et al.
        Mast cell–induced immunopathology in recurrent pregnancy losses.
        Am J Reprod Immunol. 2019; 82: e13128
        • Ciach K.
        • Niedoszytko M.
        • Abacjew-Chmylko A.
        • et al.
        Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).
        PLoS One. 2016; 11: e0146924
        • Pardanani A.
        Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
        Am J Hematol. 2019; 94: 363-377
        • Simionescu A.A.
        • Stanescu A.M.A.
        • Popescu F.D.
        State-of-the-Art on Biomarkers for Anaphylaxis in Obstetrics.
        Life (Basel). 2021; 11https://doi.org/10.3390/life11090870
        • Valent P.
        • Akin C.
        • Metcalfe D.D.
        Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.
        Blood. 2017; 129: 1420-1427
        • Giannetti M.P.
        Treatment of systemic mastocytosis: Novel and emerging therapies.
        Ann Allergy Asthma Immunol. 2021; 127: 412-419
        • Bose P.
        • Verstovsek S.
        Avapritinib for Systemic Mastocytosis.
        Expert Rev Hematol. 2021; 14: 687-696
        • Greene M.F.
        FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
        Semin Perinatol. 2015; 39: 520-523
        • Brucker M.C.
        • King T.L.
        The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
        J Midwifery Womens Health. 2017; 62: 308-316
        • Butterfield J.
        • Weiler C.R.
        The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome.
        J Allergy Clin Immunol In Pract. 2020; 8: 2533-2541
        • Gilboa S.M.
        • Ailes E.C.
        • Rai R.P.
        • et al.
        Antihistamines and birth defects: a systematic review of the literature.
        Expert Opin Drug Saf. 2014; 13: 1667-1698
        • Minutello K.
        • Gupta V.
        Cromolyn sodium.
        StatPearls Publishing, Treasure Island (FL)2021
        • Tolar J.
        • Tope W.D.
        • Neglia J.P.
        Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
        N Engl J Med. 2004; 350: 735-736
        • Sarkar M.
        • Koren G.
        • Kalra S.
        • et al.
        Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.
        Eur J Clin Pharmacol. 2009; 65: 1259-1264
        • Bonham C.A.
        • Patterson K.C.
        • Strek M.E.
        Asthma Outcomes and Management During Pregnancy.
        Chest. 2018; 153: 515-527
        • Namazy J.A.
        • Blais L.
        • Andrews E.B.
        • et al.
        Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.
        J Allergy Clin Immunol. 2020; 145: 528-536.e1
        • Källén B.
        Maternal use of anti-asthmatic drugs and infant congenital malformations. maternal drug use and infant congenital malformations.
        Springer International Publishing, 2019: 353-365
        • Cardet J.C.
        • Akin C.
        • Lee M.J.
        Mastocytosis: update on pharmacotherapy and future directions.
        Expert Opin Pharmacother. 2013; 14: 2033-2045
        • Hartmann K.
        • Gotlib J.
        • Akin C.
        • et al.
        Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
        J Allergy Clin Immunol. 2020; 146: 356-366. e4
        • Castells M.
        • Akin C.
        Finding the right KIT inhibitor for advanced systemic mastocytosis.
        Nat Med. 2021; 27: 2081-2082
        • Watson K.D.
        • Arendt K.W.
        • Watson W.J.
        • et al.
        Systemic mastocytosis complicating pregnancy.
        Obstet Gynecol. 2012; 119: 486-489
        • Kehoe S.L.
        • Bathgate S.L.
        • Macri C.J.
        Use of a Doula for Labor Coaching in a Patient With Indolent Systemic Mastocytosis in Pregnancy.
        Obstet Gynecol. 2006; 107: 514-516
        • Madendag I.C.
        • Madendag Y.
        • Tarhan I.
        • et al.
        Mastocytosis in Pregnancy.
        Taiwanese J Obstet Gynecol. 2010; 49: 192-196
        • Hermans M.A.W.
        • Arends N.J.T.
        • Gerth van Wijk R.
        • et al.
        Management around invasive procedures in mastocytosis: An update.
        Ann Allergy Asthma Immunol. 2017; 119: 304-309
        • Worobec A.S.
        • Akin C.
        • Scott L.M.
        • et al.
        Mastocytosis complicating pregnancy.
        Obstet Gynecol. 2000; 95: 391-395